Study design and rationale of a phase 2b dose-finding study of ligelizumab in adolescent patients with chronic spontaneous urticaria
B. E. Şekerel, A. Drollmann, M. Porter, N. Kataoka, A. Bienczak, M. Maurer, P. Staubach, M. Ben-Shoshan, R. Janocha, T. Severin